
RHYTHM PHARMACEUTICALS, INC.
RHYTHM PHARMACEUTICALS, INC. (RYTM)
WebsitePrice
Market cap
Next catalystExpected 2H 2026RM-718 — Prader-Willi syndrome, Part D · Enrollment completionCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P2FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2FilingApproved